• Coccidioides Antibody, IgG and IgM
  • Bacterial Culture, Upper Respiratory
  • Adrenoceptor Alpha 2A Polymorphism (ADRA2A)
  • Obstruction of bile duct
  • Staphylococcus aureus and Staph Methicillin-Resistant (MRSA) by Molecular Method
  • Toxoplasma gondii Antibody, IgG and IgM
  • Nervous System/Brain Cancer Panel, NGS
  • Cyclic AMP, Plasma
  • Lysosomal Acid Lipase, Enzyme Activity
  • Interstitial lung disease
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2)
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2)
Medical Test

Interpretation
Access to CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2) is restricted.